Status:

TERMINATED

Supplements for Controlling Resistance to Insulin

Lead Sponsor:

University of Southern California

Collaborating Sponsors:

InterHealth Nutraceuticals, Inc.

Conditions:

Obesity

Diabetes Mellitus, Type 2

Eligibility:

All Genders

13-17 years

Phase:

PHASE4

Brief Summary

The purpose of this study is to evaluate the effects of a combination of hydroxcycitrate (HCA) and niacin-bound chromium, in conjunction with nutrition education, over a twelve week period. Participan...

Detailed Description

The prevalence of obesity among youth has increased dramatically in recent years. Parallel to the increased rates of pediatric obesity, overweight children present clinically with adiposity related co...

Eligibility Criteria

Inclusion

  • Age
  • All subjects will be between 13 and 17 years of age
  • Overweight
  • All subjects will be overweight as defined by an age \& sex-specific body mass index ≥ 85th percentile based on CDC BMI growth charts \[US Department of Health and Human Services, 2000\], calculated by Epi Info Software, version 3.3.

Exclusion

  • Presently taking any prescribed medication(s) or diagnosed with any syndrome or disease that could influence dietary intake, body composition and fat distribution, or insulin action or secretion.
  • Previously diagnosed with any major illness since birth (e.g. sever intrauterine growth retardation, chronic birth asphyxia, cancer).
  • Children with type 1 and/or type 2 diabetes will be excluded are referred to a physician.
  • Currently involved with any dietary, exercise, or weight loss program or have been in the 6 months prior to participation.
  • Unexplained weight loss or gain in the prior six months.
  • Oral contraception use in sexually active females
  • Children who live further than 20 miles away from the USC Health Science Campus (HSC).

Key Trial Info

Start Date :

February 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2008

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT00699413

Start Date

February 1 2008

End Date

August 1 2008

Last Update

June 11 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

USC - Preventive Medicine

Los Angeles, California, United States, 90033